Literature DB >> 2015141

Pathological fractures and lytic bone lesion of the femoral neck associated with beta 2-microglobulin amyloid deposition in long-term dialysis patients.

G F Scheumann1, M Holch, M L Nerlich, A Brandis, H Ostertag, H Tscherne.   

Abstract

A correlation is demonstrated between chronic hemodialysis using cuprophane membranes (mean duration: 13 years) and pathological fractures (n = 7 in 6 patients) after lytic bone deposits of beta 2-microglobulin amyloid (n = 13 patients). The characteristic symptom complex includes painful impingement syndrome of the shoulder, carpal tunnel syndrome, painful hip and recurrent knee effusions. The first steps of the clinical diagnostic procedure are to demonstrate lytic defects in skeletal radiographs and to verify the presence of beta 2m by biopsy or puncture. Due to reduced regeneration capacity in amyloid bone lesions the resulting surgical therapy should aim at total joint replacement or augmented osteo synthesis. Definitive operative treatment should be aspired even in the absence of manifest fractures, as the natural course of the disease is characterized by progression of the bone destruction and a continuous pain syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015141     DOI: 10.1007/bf00393881

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  22 in total

1.  Dialysis-associated amyloidosis in a patient on long-term post-dilutional hemofiltration.

Authors:  A Argiles; G Mourad; P Berta; C Polito; B Canaud; M Robinet-Levy; C Mion
Journal:  Nephron       Date:  1987       Impact factor: 2.847

2.  beta 2-Microglobulin-derived amyloid deposition in acquired cystic disease of the kidney with renal cell carcinoma.

Authors:  I Ishikawa; T Horiguchi; H Kitada; H Matsuno; A Shinoda; Y Saito; Z Onouchi
Journal:  Nephron       Date:  1987       Impact factor: 2.847

3.  Haemodialysis-associated amyloidosis: differences in frequency between Europe and USA.

Authors:  J Varga; A Fenves
Journal:  Lancet       Date:  1987-07-25       Impact factor: 79.321

4.  [Current aspects of the osteoarticular pathology of hemodialysis patients. Results and discussion of a rheumatological survey].

Authors:  P Foissac-Gegoux; R M Flipo; P Hardouin; A Dumont; B Duquesnoy; M Lecomte-Houcke; B Delcambre
Journal:  Nephrologie       Date:  1986

5.  Beta 2-microglobulin: a new form of amyloid protein associated with chronic hemodialysis.

Authors:  F Gejyo; S Odani; T Yamada; N Honma; H Saito; Y Suzuki; Y Nakagawa; H Kobayashi; Y Maruyama; Y Hirasawa
Journal:  Kidney Int       Date:  1986-09       Impact factor: 10.612

6.  Beta-2 microglobulin is an amyloidogenic protein in man.

Authors:  P D Gorevic; T T Casey; W J Stone; C R DiRaimondo; F C Prelli; B Frangione
Journal:  J Clin Invest       Date:  1985-12       Impact factor: 14.808

7.  Aluminum in the joint tissues of chronic renal failure patients treated with regular hemodialysis and aluminum compounds.

Authors:  P Netter; M Kessler; D Burnel; M F Hutin; S Delones; J Benoit; A Gaucher
Journal:  J Rheumatol       Date:  1984-02       Impact factor: 4.666

8.  Osteoarticular amyloidosis associated with haemodialysis: an immunoultrastructural study.

Authors:  M Depierreux; M Goldman; I Fayt; C Richard; J Quintin; M Dhaene; J L Van Herweghem
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

Review 9.  beta 2-Microglobulin: structure, function and significance.

Authors:  G M Bernier
Journal:  Vox Sang       Date:  1980-06       Impact factor: 2.144

10.  Serum beta 2-microglobulin in malignant lymphoma.

Authors:  H Hagberg; A Killander; B Simonsson
Journal:  Cancer       Date:  1983-06-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.